{"title":"Magnetic resonance imaging radiomics based on artificial intelligence is helpful to evaluate the prognosis of single hepatocellular carcinoma.","authors":"Jing Zhou, Daofeng Yang, Hao Tang","doi":"10.1016/j.heliyon.2025.e41735","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Previous studies mostly use single-type features to establish a prediction model. We aim to develop a comprehensive prediction model that effectively identify patients with poor prognosis for single hepatocellular carcinoma (HCC) based on artificial intelligence (AI). <b>Patients and methods</b>: 236 single HCC patients were studied to establish a comprehensive prediction model. We collected the basic information of patients and used AI to extract the features of magnetic resonance (MR) images.</p><p><strong>Results: </strong>The clinical model based on linear regression (LR) algorithm (AUC: 0.658, 95%CI: 0.5021-0.8137), the radiomics model and deep transfer learning (DTL) model based on light gradient-boosting machine (Light GBM) algorithm (AUC: 0.761, 95%CI: 0.6326-0.8886 and AUC: 0.784, 95%CI: 0.6587-0.9087, respectively) were the optimal prediction models. A comparison revealed that the integrated nomogram had the largest area under the receiver operating characteristic curve (AUC) (all P < 0.05). In the training cohort, the integrated nomogram was predictive of recurrence-free survival (RFS) as well as overall survival (OS) (C-index: 0.735 and 0.712, P < 0.001). In the test cohort, the integrated nomogram also can predict RFS and OS (C-index: 0.718 and 0.740, P < 0.001) in patients.</p><p><strong>Conclusion: </strong>The integrated nomogram composed of signatures in the prediction models can not only predict the postoperative recurrence of single HCC patients but also stratify the risk of OS after the operation.</p>","PeriodicalId":12894,"journal":{"name":"Heliyon","volume":"11 1","pages":"e41735"},"PeriodicalIF":3.4000,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11761343/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heliyon","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.1016/j.heliyon.2025.e41735","RegionNum":3,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/15 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Previous studies mostly use single-type features to establish a prediction model. We aim to develop a comprehensive prediction model that effectively identify patients with poor prognosis for single hepatocellular carcinoma (HCC) based on artificial intelligence (AI). Patients and methods: 236 single HCC patients were studied to establish a comprehensive prediction model. We collected the basic information of patients and used AI to extract the features of magnetic resonance (MR) images.
Results: The clinical model based on linear regression (LR) algorithm (AUC: 0.658, 95%CI: 0.5021-0.8137), the radiomics model and deep transfer learning (DTL) model based on light gradient-boosting machine (Light GBM) algorithm (AUC: 0.761, 95%CI: 0.6326-0.8886 and AUC: 0.784, 95%CI: 0.6587-0.9087, respectively) were the optimal prediction models. A comparison revealed that the integrated nomogram had the largest area under the receiver operating characteristic curve (AUC) (all P < 0.05). In the training cohort, the integrated nomogram was predictive of recurrence-free survival (RFS) as well as overall survival (OS) (C-index: 0.735 and 0.712, P < 0.001). In the test cohort, the integrated nomogram also can predict RFS and OS (C-index: 0.718 and 0.740, P < 0.001) in patients.
Conclusion: The integrated nomogram composed of signatures in the prediction models can not only predict the postoperative recurrence of single HCC patients but also stratify the risk of OS after the operation.
期刊介绍:
Heliyon is an all-science, open access journal that is part of the Cell Press family. Any paper reporting scientifically accurate and valuable research, which adheres to accepted ethical and scientific publishing standards, will be considered for publication. Our growing team of dedicated section editors, along with our in-house team, handle your paper and manage the publication process end-to-end, giving your research the editorial support it deserves.